Literature DB >> 17845280

Is bipolar disorder overdiagnosed among patients with substance abuse?

Christopher Stewart1, Rif S El-Mallakh.   

Abstract

BACKGROUND: Bipolar illness is frequently misdiagnosed. Several studies have focused on the underdiagnosis of this condition and the frequent long delay in its recognition. However, the illness is difficult to diagnose and many of its symptoms are shared by other conditions. In order to determine the accuracy of the diagnosis of bipolar illness among subjects with substance abuse, we carried out a study in patients with a previous diagnosis of bipolar disorder (BD) and known history of substance abuse or dependence, who were currently engaged in treatment for substance abuse.
METHODS: Individuals participating in a community-based substance treatment program and who had a previous diagnosis of BD were invited to undergo a structured clinical interview for diagnosis performed by a psychiatrist. In addition to the interview, previous hospital records were reviewed whenever possible. Diagnosis was made following strict DSM-IV criteria.
RESULTS: Only 9 of 21 (42.9%) subjects met diagnostic criteria for BD. Seven were BD type II and two were BD I.
CONCLUSIONS: Bipolar disorder is frequently misdiagnosed following strict DSM-IV criteria. Among subjects with substance abuse, it may be overdiagnosed by psychiatrists.

Entities:  

Mesh:

Year:  2007        PMID: 17845280     DOI: 10.1111/j.1399-5618.2007.00465.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  10 in total

Review 1.  The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.

Authors:  Sean H Yutzy; Chad R Woofter; Christopher C Abbott; Imad M Melhem; Brooke S Parish
Journal:  J Nerv Ment Dis       Date:  2012-05       Impact factor: 2.254

Review 2.  Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder.

Authors:  Mark Zimmerman; Theresa A Morgan
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 3.  Subthreshold bipolarity: diagnostic issues and challenges.

Authors:  Robin Nusslock; Ellen Frank
Journal:  Bipolar Disord       Date:  2011 Nov-Dec       Impact factor: 6.744

4.  Bipolar spectrum in major depressive disorders.

Authors:  J Angst; K R Merikangas; L Cui; A Van Meter; V Ajdacic-Gross; W Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-07-21       Impact factor: 5.270

Review 5.  Prospective: Is bipolar disorder being overdiagnosed?

Authors:  Tammas Kelly
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

Review 6.  Early-onset bipolar spectrum disorders: diagnostic issues.

Authors:  Stephanie Danner; Mary A Fristad; L Eugene Arnold; Eric A Youngstrom; Boris Birmaher; Sarah M Horwitz; Christine Demeter; Robert L Findling; Robert A Kowatch
Journal:  Clin Child Fam Psychol Rev       Date:  2009-09

7.  Aripiprazole in the acute and maintenance phase of bipolar I disorder.

Authors:  Melanie Zupancic; Misty L Gonzalez
Journal:  Ther Clin Risk Manag       Date:  2012-01-12       Impact factor: 2.423

8.  Diagnostic disagreements in bipolar disorder: the role of substance abuse comorbidities.

Authors:  Rowena Shalini Theodore; Monica Ramirez Basco; John R Biggan
Journal:  Depress Res Treat       Date:  2012-01-26

Review 9.  Overdiagnosis of bipolar disorder: a critical analysis of the literature.

Authors:  Amna A Ghouse; Marsal Sanches; Giovana Zunta-Soares; Alan C Swann; Jair C Soares
Journal:  ScientificWorldJournal       Date:  2013-11-20

10.  Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder.

Authors:  Vincenzo Oliva; Michele De Prisco; Maria Teresa Pons-Cabrera; Pablo Guzmán; Gerard Anmella; Diego Hidalgo-Mazzei; Iria Grande; Giuseppe Fanelli; Chiara Fabbri; Alessandro Serretti; Michele Fornaro; Felice Iasevoli; Andrea de Bartolomeis; Andrea Murru; Eduard Vieta; Giovanna Fico
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.